Article

Daily Medication Pearl: Besifloxacin (Besivance)

Besifloxacin ophthalmic suspension (Besivance) is indicated for the treatment of bacterial conjunctivitis.

Medication Pearl of the Day: Besivance (besifloxacin)

Indication: Besifloxacin ophthalmic suspension (Besivance) 0.6% is a quinolone antimicrobial indicated for the treatment of bacterial conjunctivitis.

Insight:

  • Dosing: Instill 1 drop in the affected eye(s) 3 times a day, 4 to 12 hours apart for 7 days.
  • Dosage forms:Ophthalmic suspension besifloxacin 6 mg/mL.
  • Adverse events: The most common adverse reaction reported in 2% of patients treated with Besivance was conjunctival redness.
  • Mechanism of action: Besifloxacin is a fluoroquinolone antibacterial agent.
  • Manufacturer: Bausch & Lomb Incorporated.

Sources:

Newsletter

Stay informed on drug updates, treatment guidelines, and pharmacy practice trends—subscribe to Pharmacy Times for weekly clinical insights.

Related Videos
Image credit:  Artur | stock.adobe.com
Cardiovascular disease doctor or cardiologist holding red heart in clinic or hospital exam room office for csr professional medical service, cardiology health care and world heart health day concept - Image credit: Chinnapong | stock.adobe.com